发明名称 |
Factor II and fibrinogen for treatment of haemostatic disorders |
摘要 |
The present invention relates to normalizing impaired haemostasis comprising administering a clotting factor treatment selected from the group consisting of (1) FII; (2) PCC; and (3) a three factor combination of FII, FX, and FVIIa. The clotting factor treatment can be administered in combination with fibrinogen. The clotting factor(s) can be recombinant human clotting factor(s). |
申请公布号 |
AU2011313505(A1) |
申请公布日期 |
2013.04.11 |
申请号 |
AU20110313505 |
申请日期 |
2011.09.19 |
申请人 |
MEDIMMUNE LIMITED |
发明人 |
LOVGREN, ANN;HANSSON, KENNY |
分类号 |
A61K38/36;A61K38/48;A61P7/04 |
主分类号 |
A61K38/36 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|